China-based in vitro fertilization (IVF) specialist Suzhou Basecare Medical Co., Ltd (HKG: 2170) has announced that it has received marketing approval for its intelligent sperm quality analyzer, BKA210, in Jiangsu province. This marks the world’s first device capable of detecting unstained live sperm, offering a significant advancement in the field of sperm analysis.
BKA210: A Revolutionary Leap in Sperm Detection Technology
Traditional sperm detection techniques, which are primarily based on computer-aided sperm analysis (CASA) methods, analyze indicators such as sperm quantity, vitality, and morphology. These methods require the staining of sperm samples and rely on manual operation, leading to poor reliability and reproducibility. Moreover, they are incapable of detecting the morphology of live sperm. The process is time-consuming, requiring multiple hospital visits and a week-long wait for test results.
BKA210’s AI-Powered Analysis Streamlines Sperm Testing
BKA210 employs AI technology for analysis, eliminating the need for staining sperm samples. It can rapidly complete the analysis of morphology, concentration, and vitality of unstained live sperm within just 3 minutes at the fastest rate. This innovation allows patients to undergo a single test to identify qualified sperm suitable for embryo culture, greatly enhancing their service experience and efficiency.- Flcube.com
